Evidence map›Paper›PMID 18624908›Full record

ArticleJournal of neurochemistry2008

Transregulation of leukemia inhibitory [corrected] factor receptor expression and function by growth factors in neuroblastoma cells.

Martha D Port, George S Laszlo, Neil M Nathanson

Erratum issuedOpen access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Martha D PortDepartment of Pharmacology, University of Washington, School of Medicine, Seattle, Washington, USA.
George S Laszlo
Neil M Nathanson
University of Washington · US

Funding

NEUROBIOLOGYT32GM007108 · NIGMS · UNIVERSITY OF WASHINGTON · PI BINDER, MARC D · 1985 to 2014
$6.1M
MOLECULAR ANALYSIS OF NEUROKINE SIGNAL TRANSDUCTIONR01NS034010 · NINDS · UNIVERSITY OF WASHINGTON · PI NATHANSON, NEIL MARC · 1995 to 2004
$1.3M
NIGMS NIH HHS GM07108NIGMS NIH HHS GM07727NIGMS NIH HHS T32 GM007108NINDS NIH HHS NS30410NINDS NIH HHS R01 NS034010
6 · The paper itself

Abstract

The cytokines that signal through the leukemia inhibitory factor (LIF) receptor are members of the neuropoietic cytokine family and have varied and numerous roles in the nervous system. In this report, we have determined the effects of growth factor stimulation on LIF receptor (LIFR) expression and signal transduction in the human neuroblastoma cell line NBFL. We show here that stimulation of NBFL cells with either epidermal growth factor or fibroblast growth factor decreases the level of LIFR in an extracellular signal-regulated kinase (Erk)1/2-dependent manner and that this down-regulation is due to an increase in the apparent rate of lysosomal LIFR degradation. Growth factor-induced decreases in LIFR level inhibit both LIF-stimulated phosphorylation of signal transducers and activators of transcription 3 and LIFR-mediated gene induction. We also show that Ser1044 of LIFR, which we have previously shown to be phosphorylated by Erk1/2, is required for the inhibitory effects of growth factors. Neurons are exposed to varying combinations and concentrations of growth factors and cytokines that influence their growth, development, differentiation, and repair in vivo. These findings demonstrate that LIFR expression and signaling in neuroblastoma cells can be regulated by growth factors that are potent activators of the mitogen-activated protein kinase pathway, and thus illustrate a fundamental mechanism that underlies crosstalk between receptor tyrosine kinase and neuropoietic cytokine signaling pathways.

Indexed as

AnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansIntercellular Signaling Peptides and ProteinsMiceNeuroblastomaRatsReceptor Cross-TalkReceptors, OSM-LIFSignal TransductionTranscriptional ActivationIntercellular Signaling Peptides and ProteinsReceptors, OSM-LIF

Identifiers

PMID18624908
PMCPMC2615047
OpenAlexW1998870062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.